BCCIP

BRCA2 and CDKN1A-interacting protein · Q9P287 · BCCIP on Sugi Atlas →

0 patent compounds predicted against BCCIP, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to BCCIP by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis PHASE2ACTIVE_NOT_RECRUITING
A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects PHASE1/PHASE2COMPLETED
BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy PHASE2COMPLETED
Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation PHASE2UNKNOWN
Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation PHASE2UNKNOWN
Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations PHASE2COMPLETED
Phase II ABT-888 With Cyclophosphamide PHASE2COMPLETED
Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer PHASE2UNKNOWN
M6620 (VX-970) in Selected Solid Tumors PHASE2COMPLETED
A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation PHASE2COMPLETED
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation PHASE1RECRUITING
AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer PHASE1COMPLETED
Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors PHASE1ACTIVE_NOT_RECRUITING
Study on Fertility Parameters in Women With Germline Variants in BRCA1 and BRCA2 nanNOT_YET_RECRUITING
Genes Contributing to Hereditary Ovarian Cancer in Women and BRCA1/2 Wildtype Families nanCOMPLETED
Genetics of Prostate Cancer in Young Patients nanCOMPLETED
Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent, or 2 Separate Types of Cancer) nanCOMPLETED
Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer nanRECRUITING
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer nanACTIVE_NOT_RECRUITING
Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian Cancer nanUNKNOWN
Endocrine Disruptors and Life STILe in Breast Cancer Development nanUNKNOWN
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome nanRECRUITING
Adherence to Intensive Surveillance for Hereditary Breast Cancer nanCOMPLETED
The Genetic Education for Men Trial: Web-Based Education vs. Standard Care nanCOMPLETED
A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women nanCOMPLETED
Prophylactic Irradiation to the Contralateral Breast for BCAs Patients nanRECRUITING
Physical Activity for Adults in the Ontario Breast Screening Program nanNOT_YET_RECRUITING
An INternational Frontline Ovarian Cancer Real World Management Study nanCOMPLETED
Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a BCCIP binder may also engage these)

ProteinNameSimilarity
Q2U600 1.000 Q2U600 →
Q5ZK14 1.000 Q5ZK14 →
Q6GNI0 1.000 Q6GNI0 →
Q0GBX8 1.000 Q0GBX8 →
P0DQH9 0.999 P0DQH9 →
P03209 0.999 P03209 →
A5WWB6 0.999 A5WWB6 →
A4IFN2 0.997 A4IFN2 →
P11468 0.997 P11468 →
Q2NL37 0.997 Q2NL37 →
Q5RD13 0.997 Q5RD13 →
Q9CWI3 0.997 Q9CWI3 →
O10327 0.997 O10327 →
Q9QJ30 0.996 Q9QJ30 →
Q5U550 0.996 Q5U550 →
Q6GL92 0.996 Q6GL92 →
Q89462 0.996 Q89462 →
P36595 0.996 P36595 →
Q9BXN6 0.996 Q9BXN6 →
Q6RSS2 0.996 Q6RSS2 →
Q8PW88 0.996 Q8PW88 →
P34566 0.996 P34566 →
A2Y4R8 0.996 A2Y4R8 →
Q08314 0.996 Q08314 →
Q60DW3 0.996 Q60DW3 →
B3P773 0.996 B3P773 →
P0C657 0.996 P0C657 →
P04601 0.996 P04601 →
C8ZC45 0.996 C8ZC45 →
P36068 0.996 P36068 →